xbiotech.com - XBIT Operating profit EBITDA
XBiotech Inc. possesses high macro-resilience due to its liquidity reserves and the non-cyclical nature of oncology research. Therapy development is conducted in collaboration with global medical centers, while the platform's patent protection creates a robust barrier for competitors. The volume of EBITDA demonstrates the business's real cash return, where the 0.00 mark reflects the company's current capacity for scaling.
XBiotech (XBIT) - metric breakdowns and financial figures
- current quotes and average value forecast:
- issuer market value details:
- book value of equity indicators:
- debt level and financial liquidity data:
- earnings and market ratios statistics:
XBIT - Net Profit|Expected Net Profit XBiotech Inc.|XBIT - P/E Multiple|Projected Price to Earnings XBiotech Inc|XBIT - PEG Multiple|Business Value to Operating Income Before Depreciation XBiotech|XBIT - Operating profit before deduction of amortization|Earnings per share for the trailing year XBiotech|XBIT - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months xbiotech.com|XBIT - Earnings per share growth in current year|Projected earnings per share growth rate for next year XBiotech Inc.
Summary company analytics:XBIT XBiotech Inc.
For XBiotech Inc. (XBIT), protected by True Human patents under strict FDA oversight, the actual scale of operations determines business viability. This operating profit figure reflects the net cash flow before taxes and interest, allowing investors to strip away speculative noise from actual efficiency, where a steady upward curve confirms the issuer's fundamental strength, while sharp spikes signal the risk of overpayment.
Competitors of XBiotech Inc. (XBIT)
ONC - Operating profit before deduction of amortization|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage Pharma (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Inc - Income before deduction of interest, taxes and amortization|URGN (UroGen) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Corp BCAX|Operating profit before deduction of amortization PSNL (Personalis, Inc.)|erasca.com - Operating profit before amortization|Operating profit EBITDA DCTH (Delcath Systems)|Y-mAbs Therapeutics Inc - Profit before payment of interest, taxes and amortization|Aura Bio - Operating profit EBITDA|Operating income before deduction of amortization Candel Therapeutics CADL|Accuray Incorporated (ARAY) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization SELLAS Life Sciences Group (SLS)|Operating profit before deduction of amortization ACTU|CTOR (Citius Oncology Inc.) - Company profit before taxes, interest and amortization|Operating profit EBITDA HURA|TARA - Profit before interest, taxes and amortization|Operating profit EBITDA FATE (Fate Therapeutics, Inc.)|WHWK - Operating profit before deduction of amortization|TScan - Operating profit EBITDA|Income before deduction of interest, taxes and amortization CSBR (Champions Oncology)|CVM (cel-sci.com) - Operating profit before deduction of amortization|OS Therapies, Inc. - Income before deduction of interest, taxes and amortization|RADX (Radiopharm Theranostics) - Operating profit EBITDA|Artiva (ARTV) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Adlai Nortye Ltd. (ANL)|Veru Inc - Operating profit before amortization|Operating profit EBITDA TPST (Tempest Tx)|XLO - Operating profit before deduction of amortization|RENB: Operating profit before deduction of amortization|Operating income before deduction of amortization Mural Oncology plc MURA|KAPA (kairospharma.com) - Operating profit before deduction of amortization|Operating profit before amortization OKUR|GDTC (CytoMed Therapeutics Ltd) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization CRIS|Operating profit EBITDA APLM|Operating income before deduction of amortization tharimmune.com|Advanced Biomed - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization GNPX (Genprex Inc.)|Calidi Bio - Operating profit EBITDA|sunshinebiopharma.com (SBFM) - Operating profit before deduction of amortization|XBIO: Operating profit EBITDA|salariuspharma.com (SLRX) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Purple Biotech Ltd.|Operating profit before amortization AONC (AON)|Operating profit EBITDA BGNE|Operating profit before deduction of amortization Checkpoint Therapeutics Inc CKPT|Operating profit EBITDA ELEV (Elevation Oncology)|iCAD Inc. (ICAD) - Profit before interest, taxes and amortization|IKNA - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization NTBL (Notable Labs Ltd)|VIRX (viracta.com) - Operating profit before deduction of amortization|MorphoSys Corporation - Income before deduction of interest, taxes and amortization|NAYA (NAYA Biosciences) - Operating profit EBITDA|Operating profit before deduction of amortization ascentage.com (AAPGV)
